Solumed Sp. z o.o. sp.k.

At Solumed Centrum Medyczne in Poznan, research in digestive system diseases focuses on Crohn’s disease, ulcerative colitis, and coeliac disease. These studies are designed to assess new treatment options, improve disease control, and better understand how to achieve deeper and longer-lasting remission.

• Evaluating therapies for active Crohn’s disease and maintaining response over time
• Studying treatment approaches for ulcerative colitis to improve symptoms and intestinal healing
• Exploring new options for non-responsive coeliac disease and related mucosal changes

This area represents a major part of the site’s clinical research activity, with a strong emphasis on both induction and maintenance of disease control.

The site also conducts extensive research in skin and connective tissue diseases and immune system diseases, with studies in plaque psoriasis, atopic dermatitis, chronic spontaneous urticaria, hidradenitis suppurativa, and prurigo nodularis. The main goal is to test new therapies that may reduce inflammation, improve skin symptoms, and support better long-term disease management.

• Testing treatments for moderate to severe plaque psoriasis and difficult-to-treat forms affecting special areas
• Assessing therapies for atopic dermatitis, chronic spontaneous urticaria, and prurigo nodularis
• Investigating new approaches for hidradenitis suppurativa to reduce lesion burden and improve quality of life

These trials reflect a strong focus on immune-driven skin disorders and the search for more effective, targeted treatment strategies.

Clinical research in nervous system diseases is centered on migraine, including chronic migraine and episodic migraine. The studies aim to evaluate preventive therapies that may reduce headache frequency, lessen disease impact, and offer better tolerability for people needing long-term management.

• Studying preventive treatment options for chronic migraine
• Evaluating therapies for episodic migraine and broader migraine prevention
• Assessing safety, tolerability, and effectiveness of new migraine-focused approaches

Migraine research is a prominent theme at the site, showing a clear interest in improving everyday symptom control for patients with recurrent headache disorders.

In the field of cardiovascular diseases, the site is involved in studies on atherosclerotic cardiovascular disease and prevention of stroke or systemic embolism in people with atrial fibrillation. These trials are intended to compare treatment effectiveness and safety while looking for better ways to reduce serious cardiovascular events.

• Testing therapies aimed at lowering the risk of major cardiovascular events
• Evaluating prevention strategies for atrial fibrillation-related stroke and embolic complications
• Comparing treatment benefit and bleeding risk in high-risk cardiovascular populations

This research area highlights the site’s contribution to cardiovascular prevention studies, especially where long-term safety and event reduction are key priorities.

The site’s work in musculoskeletal diseases includes rheumatoid arthritis, psoriatic arthritis, and osteoporosis. Research here focuses on improving inflammatory joint disease control, comparing treatment performance, and evaluating options that may support bone health in postmenopausal women.

• Assessing therapies for active rheumatoid arthritis and treatment response
• Studying options for psoriatic arthritis in patients who need better disease control
• Comparing approaches for osteoporosis to support bone strength and reduce fracture risk

These studies show a balanced focus on inflammatory and degenerative conditions, with an emphasis on effectiveness, safety, and practical treatment improvement.

Additional studies at the site cover broader immune system diseases and wound-related conditions such as venous leg ulcer. The purpose of this research is to explore new ways to support tissue healing, reduce disease activity, and improve outcomes in conditions where inflammation or impaired repair plays a major role.

• Investigating therapies for immune-mediated inflammatory conditions
• Evaluating treatment approaches for venous leg ulcer wound preparation and healing
• Supporting research into better disease control across multiple chronic inflammatory disorders

At Solumed Sp. z o.o. sp.k., this diverse portfolio reflects a broad commitment to testing innovative treatments across several chronic disease areas.